Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $528.59 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $173.20 | 12 | $0 (2024) |
| Amgen Inc. | $96.48 | 6 | $0 (2022) |
| ABBVIE INC. | $54.22 | 4 | $0 (2024) |
| Electromed, Inc. | $43.00 | 4 | $0 (2024) |
| Abbott Laboratories | $27.92 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $27.58 | 2 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $20.45 | 1 | $0 (2024) |
| Philips Electronics North America Corporation | $18.53 | 1 | $0 (2020) |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.21 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $14.25 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $93.68 | 6 | Electromed, Inc. ($24.53) |
| 2023 | $18.71 | 2 | Novo Nordisk Inc ($15.74) |
| 2022 | $70.19 | 6 | Electromed, Inc. ($18.47) |
| 2021 | $91.38 | 6 | AbbVie Inc. ($34.90) |
| 2020 | $62.51 | 4 | Philips Electronics North America Corporation ($18.53) |
| 2019 | $11.60 | 1 | Novo Nordisk Inc ($11.60) |
| 2018 | $84.40 | 5 | Amgen Inc. ($44.73) |
| 2017 | $96.12 | 7 | Novo Nordisk Inc ($49.30) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: HFCWO | ||||||
| 04/16/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.33 | General |
| Category: HFCWO | ||||||
| 03/27/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/03/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $2.97 | General |
| Category: SURGERY | ||||||
| 06/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Diabetes | ||||||
| 12/16/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $9.41 | General |
| Category: HFCWO | ||||||
| 11/12/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: PRIMARY CARE | ||||||
| 09/23/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $9.06 | General |
| Category: HFCWO | ||||||
| 08/30/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/28/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Diabetes | ||||||
| 01/21/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Bone Health | ||||||
| 10/18/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/26/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/22/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/22/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Neuromodulation | ||||||
| 03/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Diabetes | ||||||
| 01/20/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/24/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Inflammation | ||||||
| 09/25/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 04/22/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/20/2020 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $18.53 | General |
| Category: Dental and Oral Health | ||||||
| 03/05/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 83 | 149 | $21,677 | $8,298 |
| 2022 | 4 | 134 | 250 | $37,086 | $12,759 |
| 2021 | 4 | 154 | 301 | $44,121 | $15,445 |
| 2020 | 4 | 170 | 306 | $40,598 | $15,978 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 88 | $13,464 | $4,961 | 36.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 37 | 45 | $6,885 | $2,743 | 39.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 16 | $1,328 | $593.76 | 44.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 60 | 162 | $24,786 | $8,544 | 34.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 51 | 61 | $9,333 | $3,303 | 35.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 12 | $2,532 | $817.87 | 32.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 12 | 15 | $435.00 | $94.38 | 21.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 58 | 188 | $28,764 | $10,084 | 35.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 56 | 71 | $10,863 | $3,842 | 35.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 18 | 18 | $3,798 | $1,365 | 35.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 22 | 24 | $696.00 | $154.32 | 22.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 72 | 188 | $26,298 | $10,428 | 39.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 59 | 73 | $10,143 | $4,122 | 40.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 17 | 17 | $3,345 | $1,249 | 37.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 22 | 28 | $812.00 | $179.05 | 22.1% |
About Dr. Anthony Kusek, MD
Dr. Anthony Kusek, MD is a Family Medicine healthcare provider based in Albion, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760417901.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Kusek, MD has received a total of $528.59 in payments from pharmaceutical and medical device companies, with $93.68 received in 2024. These payments were reported across 37 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($528.59).
As a Medicare-enrolled provider, Kusek has provided services to 541 Medicare beneficiaries, totaling 1,006 services with total Medicare billing of $52,479. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Albion, NE
- Active Since 07/12/2006
- Last Updated 07/16/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760417901
Products in Payments
- Ozempic (Drug) $84.17
- Prolia (Biological) $51.88
- SMARTVEST (Device) $43.00
- Victoza (Drug) $37.46
- DALVANCE (Drug) $34.91
- TEFLARO (Drug) $30.48
- Proclaim IPG (Device) $27.92
- ENTRESTO (Drug) $27.58
- Tresiba (Drug) $23.99
- REXULTI (Drug) $20.45
- (8874) inCourage (Device) $18.53
- Otezla (Drug) $17.46
- Rybelsus (Drug) $15.74
- NURTEC ODT (Drug) $15.21
- Repatha (Biological) $15.12
- ANORO (Drug) $14.25
- YUPELRI (Drug) $13.31
- EVENITY (Biological) $12.02
- Xultophy 100/3.6 (Drug) $11.84
- INVOKANA (Drug) $10.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Albion
David Bodosky, Do, DO
Family Medicine — Payments: $15,514
Michael Engle, D.o, D.O
Family Medicine — Payments: $3,552
Miss. Eileen Kosieracki, D.o, D.O
Family Medicine — Payments: $2,821
Dr. Sean Kohl, Md, MD
Family Medicine — Payments: $1,094
Peter Kroemer, Md, MD
Family Medicine — Payments: $649.84
Dr. Lynette Kramer, Md, MD
Family Medicine — Payments: $317.93